Association between DNA Methylation in whole blood and measures of glucose metabolism: Kora F4 study

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Kriebel, Jennifer ^a,b   Herder, Christian ^b,c   Rathmann, Wolfgang ^c   Wahl, Simone ^a,b   Kunze, Sonja ^a   Molnos, Sophie ^a,b   Volkova, Nadezda ^a   Schramm, Katharina ^a,d   Carstense Kirberg, Maren ^b,c   Waldenberger, Melanie ^a   Gieger, Christian ^a   Peters, Annette ^a,b   Illig, Thomas ^e   Prokisch, Holger ^a,d   Roden, Michael ^b,c,f   Grallert, Harald ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; GLUCOSE; INSULIN; ABC TRANSPORTER; ABCG1 PROTEIN, HUMAN; DNA; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BODY MASS; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SMOKING; ANALYSIS; BLOOD; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GERMANY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 1; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD GLUCOSE; BODY MASS INDEX; CPG ISLANDS; DIABETES MELLITUS, TYPE 2; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GERMANY; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; PHENOTYPE;

EID: 84962170623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152314     Document Type: Article

References (93)

1. Tamayo T, Rosenbauer J, Wild SH, Spijkerman AM, Baan C, Forouhi NG, et al. Diabetes in Europe: an update. Diabetes Res Clin Pract. 2014;103(2):206-17. doi: 10.1016/j.diabres.2013.11.007 PMID: 24300019
2. Rathmann W, Scheidt-Nave C, Roden M, Herder C. Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction. Deutsches Arzteblatt international. 2013;110(19):331-7. doi: 10.3238/arztebl.2013.0331 PMID: 23762204
3. Travers ME, McCarthy MI. Type 2 diabetes and obesity: genomics and the clinic. Hum Genet. 2011;130(1):41-58. doi: 10.1007/s00439-011-1023-8 PMID: 21647602
4. Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A. Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes. 2005;54(1):275-83. PMID: 15616039
5. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia. 1999;42(2):139-45. PMID: 10064092
6. Schousboe K, Visscher PM, Henriksen JE, Hopper JL, Sorensen TI, Kyvik KO. Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia. 2003;46(9):1276-83. PMID: 12898014
7. Schwenk RW, Vogel H, Schurmann A. Genetic and epigenetic control of metabolic health. Molecular metabolism. 2013;2(4):337-47. doi: 10.1016/j.molmet.2013.09.002 PMID: 24327950
8. Morris A, Voight BF, Teslovich TM, Ferreira T. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981-90. doi: 10.1038/ng.2383 PMID: 22885922
9. Basile KJ, Johnson ME, Xia Q, Grant SF. Genetic susceptibility to type 2 diabetes and obesity: followup of findings from genome-wide association studies. International journal of endocrinology. 2014;2014:769671. doi: 10.1155/2014/769671 PMID: 24719615
10. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579-89. doi: 10.1038/ng.609 PMID: 20581827
11. Marullo L, El-Sayed Moustafa JS, Prokopenko I. Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of glycaemic traits. Curr Diab Rep. 2014;14(11):551. doi: 10.1007/s11892-014-0551-8 PMID: 25344220
12. Replication DIG, Meta-analysis C, Asian Genetic Epidemiology Network Type 2 Diabetes C, South Asian Type 2 Diabetes C, Mexican American Type 2 Diabetes C, Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples C, et al. Genome-wide trans-ancestry metaanalysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46(3):234-44. doi: 10.1038/ng.2897 PMID: 24509480
13. Herder C, Roden M. Genetics of type 2 diabetes: pathophysiologic and clinical relevance. Eur J Clin Invest. 2011;41(6):679-92. doi: 10.1111/j.1365-2362.2010.02454.x PMID: 21198561
14. Barres R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell metabolism. 2009;10(3):189-98. doi: 10.1016/j.cmet.2009.07.011 PMID: 19723495
15. Bell CG, Finer S, Lindgren CM, Wilson GA, Rakyan VK, Teschendorff AE, et al. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One. 2010;5(11):e14040. doi: 10.1371/journal.pone.0014040 PMID: 21124985
16. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B, et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet. 2012;21(2):371-83. doi: 10.1093/hmg/ddr472 PMID: 21994764
17. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333-46. PMID: 15823385
18. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279-90. doi: 10.1016/S0140-6736 (12) 60283-9 PMID: 22683128
19. Holle R, Happich M, Lowel H, Wichmann HE. KORA-a research platform for population based health research. Gesundheitswesen. 2005;67 Suppl 1:S19-25. PMID: 16032513
20. Steffens M, Lamina C, Illig T, Bettecken T, Vogler R, Entz P, et al. SNP-based analysis of genetic substructure in the German population. Hum Hered. 2006;62(1):20-9. PMID: 17003564
21. Zeilinger S, Kuhnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C, et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One. 2013;8(5):e63812. doi: 10.1371/journal.pone.0063812 PMID: 23691101
22. American Diabetes A. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37 Suppl 1:S14-80. doi: 10.2337/dc14-S014 PMID: 24357209
23. Schurmann C, Heim K, Schillert A, Blankenberg S, Carstensen M, Dorr M, et al. Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium. PLoS One. 2012;7(12):e50938. doi: 10.1371/journal.pone.0050938 PMID: 23236413
24. Rathmann W, Kowall B, Tamayo T, Giani G, Holle R, Thorand B, et al. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med. 2012;44(2):170-7. doi: 10.3109/07853890.2010.531759 PMID: 21091229
25. Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G, et al. Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med. 2009;26(12):1212-9. doi: 10.1111/j.1464-5491.2009.02863.x PMID: 20002472
26. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46(2):182-9. PMID: 12627316
27. Herder C, Ouwens DM, Carstensen M, Kowall B, Huth C, Meisinger C, et al. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur J Endocrinol. 2015;172(4):423-32. doi: 10.1530/EJE-14-0879 PMID: 25733068
28. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA methylation array with single CpG site resolution. Genomics. 2011;98(4):288-95. doi: 10.1016/j.ygeno. 2011.07.007 PMID: 21839163
29. Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450, 000 CpG sites in the human genome. Epigenetics: official journal of the DNA Methylation Society. 2011;6(6):692-702.
30. Schramm K, Marzi C, Schurmann C, Carstensen M, Reinmaa E, Biffar R, et al. Mapping the genetic architecture of gene regulation in whole blood. PLoS One. 2014;9(4):e93844. doi: 10.1371/journal. pone.0093844 PMID: 24740359
31. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013;29(2):189-96. doi: 10.1093/bioinformatics/bts680 PMID: 23175756
32. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86. doi: 10.1186/1471-2105-13-86 PMID: 22568884
33. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995;57(1):289-300.
34. Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of crossreactive probes and polymorphic CpGs in the Illumina Infinium Human Methylation 450 microarray. Epigenetics: official journal of the DNA Methylation Society. 2013;8(2):203-9.
35. Hidalgo B, Irvin MR, Sha J, Zhi D, Aslibekyan S, Absher D, et al. Epigenome-wide association study of fasting measures of glucose, insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network study. Diabetes. 2014;63(2):801-7. doi: 10.2337/db13-1100 PMID: 24170695
36. Westerterp M, Bochem AE, Yvan-Charvet L, Murphy AJ, Wang N, Tall AR. ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ Res. 2014;114(1):157-70. doi: 10.1161/CIRCRESAHA.114.300738 PMID: 24385509
37. Wilson PW, McGee DL, Kannel WB. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study. Am J Epidemiol. 1981;114(5):697-704. PMID: 7304597
38. von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster. J Clin Endocrinol Metab. 2000;85(9):3101-8. PMID: 10999793
39. Pfeiffer L, Wahl S, Pilling LC, Reischl E, Sandling JK, Kunze S, et al. DNA methylation of lipid-related genes affects blood lipid levels. Circulation Cardiovascular genetics. 2015;8(2):334-42. doi: 10.1161/CIRCGENETICS.114.000804 PMID: 25583993
40. Kruit JK, Wijesekara N, Westwell-Roper C, Vanmierlo T, de Haan W, Bhattacharjee A, et al. Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired beta-cell function. Diabetes. 2012;61(3):659-64. doi: 10.2337/db11-1341 PMID: 22315310
41. Sturek JM, Castle JD, Trace AP, Page LC, Castle AM, Evans-Molina C, et al. An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. J Clin Invest. 2010;120(7):2575-89. doi: 10.1172/JCI41280 PMID: 20530872
42. Zhou H, Li C, Li J, Yao H, Su R, Li W, et al. Associations of ATP-binding cassette transporter A1 and G1 with insulin secretion in human insulinomas. Pancreas. 2012;41(6):934-9. doi: 10.1097/MPA. 0b013e318243a5e3 PMID: 22466164
43. Johansson LE, Danielsson AP, Parikh H, Klintenberg M, Norstrom F, Groop L, et al. Differential gene expression in adipose tissue from obese human subjects during weight loss and weight maintenance. Am J Clin Nutr. 2012;96(1):196-207. doi: 10.3945/ajcn. 111.020578 PMID: 22648723
44. Mauldin JP, Nagelin MH, Wojcik AJ, Srinivasan S, Skaflen MD, Ayers CR, et al. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation. 2008;117(21):2785-92. doi: 10.1161/CIRCULATIONAHA. 107.741314 PMID: 18490524
45. Chambers JC, Loh M, Lehne B, Drong A, Kriebel J, Motta V, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015;3(7):526-34. doi: 10.1016/S2213-8587 (15) 00127-8 PMID: 26095709
46. Holliday R. Epigenetics: a historical overview. Epigenetics: official journal of the DNA Methylation Society. 2006;1(2):76-80.
47. Hou L, Zhang X, Wang D, Baccarelli A. Environmental chemical exposures and human epigenetics. International journal of epidemiology. 2012;41(1):79-105. doi: 10.1093/ije/dyr154 PMID: 22253299
48. Waki H, Yamauchi T, Kadowaki T. The Epigenome and Its Role in Diabetes. Curr Diab Rep. 2012;12(6):673-85. doi: 10.1007/s11892-012-0328-x PMID: 23070559
49. Langevin SM, Kelsey KT. The fate is not always written in the genes: epigenomics in epidemiologic studies. Environmental and molecular mutagenesis. 2013;54(7):533-41. doi: 10.1002/em.21762 PMID: 23444110
50. Vitto MF, Luz G, Luciano TF, Marques SO, Souza DR, Pinho RA, et al. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice. Horm Metab Res. 2012;44(12):885-90. doi: 10.1055/s-0032-1321819 PMID: 22932913
51. Haas JT, Miao J, Chanda D, Wang Y, Zhao E, Haas ME, et al. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell metabolism. 2012;15(6):873-84. doi: 10.1016/j.cmet.2012.05.002 PMID: 22682225
52. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-7. PMID: 17167474
53. Feingold KR, Soued M, Staprans I, Gavin LA, Donahue ME, Huang BJ, et al. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J Clin Invest. 1989;83(4):1116-21. PMID: 2703526
54. Korkmazer E, Solak N. Correlation between inflammatory markers and insulin resistance in pregnancy. Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology. 2014:1-4.
55. Xu J, Zhao YH, Chen YP, Yuan XL, Wang J, Zhu H, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. TheScientificWorldJournal. 2014;2014:926932. doi: 10.1155/2014/926932 PMID: 25202741
56. Chen X, Huang Z, Ran W, Liao G, Zha L, Wang Z. Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass. Experimental and therapeutic medicine. 2014;8(3):856-62. PMID: 25120614
57. Volpe CM, Abreu LF, Gomes PS, Gonzaga RM, Veloso CA, Nogueira-Machado JA. The production of nitric oxide, IL-6, and TNF-alpha in palmitate-stimulated PBMNCs is enhanced through hyperglycemia in diabetes. Oxidative medicine and cellular longevity. 2014;2014:479587. doi: 10.1155/2014/479587 PMID: 24803982
58. Fernandez-Veledo S, Vila-Bedmar R, Nieto-Vazquez I, Lorenzo M. c-Jun. N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. J Clin Endocrinol Metab. 2009;94(9):3583-93. doi: 10.1210/jc.2009-0558 PMID: 19567513
59. Wang Z, Lv J, Zhang R, Zhu Y, Zhu D, Sun Y, et al. Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes. Biochem Biophys Res Commun. 2006;345(3):976-83. PMID: 16712794
60. Kalninova J, Jakus V, Glejtkova M, Kuracka L, Sandorova E. Impact of glycemic control on advanced glycation and inflammation in overweight and obese patients with type 2 diabetes mellitus. Bratisl Lek Listy. 2014;115(8):457-68. PMID: 25246279
61. Marques-Vidal P, Bastardot F, von Kanel R, Paccaud F, Preisig M, Waeber G, et al. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf). 2013;78(2):232-41.
62. De Silva NM, Freathy RM, Palmer TM, Donnelly LA, Luan J, Gaunt T, et al. Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance. Diabetes. 2011;60(3):1008-18. doi: 10.2337/db10-1317 PMID: 21282362
63. Meng ZX, Yin Y, Lv JH, Sha M, Lin Y, Gao L, et al. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines. Diabetologia. 2012;55(6):1733-44. doi: 10.1007/s00125-012-2516-2 PMID: 22415588
64. Nyman LR, Tian L, Hamm DA, Schoeb TR, Gower BA, Nagy TR, et al. Long term effects of high fat or high carbohydrate diets on glucose tolerance in mice with heterozygous carnitine palmitoyltransferase-1a (CPT-1a) deficiency: Diet influences on CPT1a deficient mice. Nutrition & diabetes. 2011;1:e14.
65. Orellana-Gavalda JM, Herrero L, Malandrino MI, Paneda A, Sol Rodriguez-Pena M, Petry H, et al. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology. 2011;53(3):821-32. doi: 10.1002/hep. 24140 PMID: 21319201
66. Hirota Y, Ohara T, Zenibayashi M, Kuno S, Fukuyama K, Teranishi T, et al. Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus. Metabolism. 2007;56(5):656-61. PMID: 17445541
67. Gonzalez-Muniesa P, Marrades MP, Martinez JA, Moreno-Aliaga MJ. Differential proinflammatory and oxidative stress response and vulnerability to metabolic syndrome in habitual high-fat young male consumers putatively predisposed by their genetic background. Int J Mol Sci. 2013;14(9):17238-55. doi: 10.3390/ijms140917238 PMID: 23975165
68. Zhu L, Yu Q, Lin J, Zhang Q, Yang Q. Cloning and functional analysis of goat glucose transporter 4. Molecular biology reports. 2014;41(2):757-68. doi: 10.1007/s11033-013-2915-6 PMID: 24381100
69. Yu Q, Zhu L, Lin J, Zhang Q, Tian Q, Hu W, et al. Functional analyse of GLUT1 and GLUT12 in glucose uptake in goat mammary gland epithelial cells. PLoS One. 2013;8(5):e65013. doi: 10.1371/journal. pone.0065013 PMID: 23724114
70. Diaz M, Martel N, Fitzsimmons RL, Eriksson NA, Cowin GJ, Thomas GP, et al. Ski overexpression in skeletal muscle modulates genetic programs that control susceptibility to diet-induced obesity and insulin signaling. Obesity (Silver Spring). 2012;20(11):2157-67.
71. Leong GM, Kee AJ, Millard SM, Martel N, Eriksson N, Turner N, et al. The Ski proto-oncogene regulates body composition and suppresses lipogenesis. Int J Obes (Lond). 2010;34(3):524-36.
72. Rondas D, Tomas A, Soto-Ribeiro M, Wehrle-Haller B, Halban PA. Novel mechanistic link between focal adhesion remodeling and glucose-stimulated insulin secretion. J Biol Chem. 2012;287(4):2423-36. doi: 10.1074/jbc. M111.279885 PMID: 22139838
73. Na YK, Hong HS, Lee DH, Lee WK, Kim DS. Effect of body mass index on global DNA methylation in healthy Korean women. Molecules and cells. 2014;37(6):467-72. doi: 10.14348/molcells.2014.0073 PMID: 24938226
74. Stepanow S, Reichwald K, Huse K, Gausmann U, Nebel A, Rosenstiel P, et al. Allele-specific, agedependent and BMI-associated DNA methylation of human MCHR1. PLoS One. 2011;6(5):e17711. doi: 10.1371/journal.pone.0017711 PMID: 21637341
75. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Current opinion in pediatrics. 2009;21(2):243-51. PMID: 19663042
76. Choudhuri S, Cui Y, Klaassen CD. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicology and applied pharmacology. 2010;245(3):378-93. doi: 10.1016/j.taap. 2010.03.022 PMID: 20381512
77. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41(2):178-86. doi: 10.1038/ng.298 PMID: 19151715
78. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009;41(12):1350-3. doi: 10.1038/ng.471 PMID: 19881528
79. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nature reviews Cancer. 2011;11(10):726-34. doi: 10.1038/nrc3130 PMID: 21941284
80. Rivera RM, Bennett LB. Epigenetics in humans: an overview. Current opinion in endocrinology, diabetes, and obesity. 2010;17(6):493-9. doi: 10.1097/MED.0b013e3283404f4b PMID: 20962634
81. An W, Zhang Z, Zeng L, Yang Y, Zhu X, Wu J. Cyclin Y Is Involved in the Regulation of Adipogenesis and Lipid Production. PLoS One. 2015;10(7):e0132721. doi: 10.1371/journal.pone.0132721 PMID: 26161966
82. Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U. Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab. 2015;26(4):193-200. doi: 10.1016/j.tem.2015.01.006 PMID: 25703677
83. Henninger AM, Eliasson B, Jenndahl LE, Hammarstedt A. Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS One. 2014;9(8):e105262. doi: 10.1371/journal.pone.0105262 PMID: 25148116
84. Hirata M, Suzuki M, Ishii R, Satow R, Uchida T, Kitazumi T, et al. Genetic defect in phospholipase Cdelta1 protects mice from obesity by regulating thermogenesis and adipogenesis. Diabetes. 2011;60(7):1926-37. doi: 10.2337/db10-1500 PMID: 21617180
85. Fiume R, Ramazzotti G, Faenza I, Piazzi M, Bavelloni A, Billi AM, et al. Nuclear PLCs affect insulin secretion by targeting PPARgamma in pancreatic beta cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2012;26(1):203-10.
86. Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci. 2006;1084:89-117. PMID: 17151295
87. Kulkarni RN, Kahn CR. Ephs and ephrins keep pancreatic Beta cells connected. Cell. 2007;129(2):241-3. PMID: 17448984
88. Dorrell C, Schug J, Lin CF, Canaday PS, Fox AJ, Smirnova O, et al. Transcriptomes of the major human pancreatic cell types. Diabetologia. 2011;54(11):2832-44. doi: 10.1007/s00125-011-2283-5 PMID: 21882062
89. Jain R, Lammert E. Cell-cell interactions in the endocrine pancreas. Diabetes Obes Metab. 2009;11 Suppl 4:159-67. doi: 10.1111/j.1463-1326.2009.01102.x PMID: 19817798
90. Konstantinova I, Nikolova G, Ohara-Imaizumi M, Meda P, Kucera T, Zarbalis K, et al. EphA-Ephrin-Amediated beta cell communication regulates insulin secretion from pancreatic islets. Cell. 2007;129(2):359-70. PMID: 17448994
91. Zhang W, Thompson BJ, Hietakangas V, Cohen SM. MAPK/ERK signaling regulates insulin sensitivity to control glucose metabolism in Drosophila. PLoS Genet. 2011;7(12):e1002429. doi: 10.1371/journal. pgen. 1002429 PMID: 22242005
92. Ozaki KI, Awazu M, Tamiya M, Iwasaki Y, Harada A, Kugisaki S, et al. Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes. American journal of physiology Endocrinology and metabolism. 2016: ajpendo 00445 2015.
93. Marker T, Sell H, Zillessen P, Glode A, Kriebel J, Ouwens DM, et al. Heat shock protein 60 as a mediator of adipose tissue inflammation and insulin resistance. Diabetes. 2012;61(3):615-25. doi: 10.2337/db10-1574 PMID: 22315307